Compositions and methods
Abstract:
The present invention provides a composition comprising hepatitis C virus (HCV) Envelope 2 (E2) glycoprotein, wherein the HCV E2 is substantially monomer depleted HCV E2. Also provide are methods of inducing an HCV immune response.
Public/Granted literature
Information query
Patent Agency Ranking
0/0